Skip to content

Comparison of the intra-articular injection versus quadruple injection at the joint surface in the treatment of sacroiliac joint pain

Comparison of the intra-articular injection versus quadruple injection at the joint surface in the treatment of sacroiliac joint pain

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210725051977N3
Enrollment
40
Registered
2023-01-15
Start date
2023-02-20
Completion date
Unknown
Last updated
2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sacroiliac joint pain. Sprain of sacroiliac joint

Interventions

Intervention 1: Intervention group: Intra-articular injection Triamcinolone mixture of Hexal brand in the amount of 40 mgPlusMarcaine (bupivacaine) of Myungmoon brand is 0-25% with a volume of 8cc. I

Sponsors

Islamic Azad University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: ASA (American Society of Anesthesiologists) patients in class I and II, 18 years old and above, referred to Yazd city pain clinic, who came with complaints of back pain and during clinical examinations, they had a clinical diagnosis of SIJ joint pain.

Exclusion criteria

Exclusion criteria: History of any uncontrolled medical illness History of rheumatological or infectious diseases (RA, brucellosis)

Design outcomes

Primary

MeasureTime frame
Pain intensity. Timepoint: Pain intensity of the patient at the beginning of the study (before the start of the intervention), one hour after the injection and 4 weeks after the injection. Method of measurement: Visual Analogue Scale (VAS).

Secondary

MeasureTime frame
Frequency of side effects in each group. Timepoint: one hour after the injection and 4 weeks after the injection. Method of measurement: check list including possible adverse (including injection site infection, pain aggravation, etc.).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Masoud Khoshbin

Islamic Azad University

masoudkhoshbin@iauyazd.ac.ir+98 35 3138 0155

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026